Summary. Serum from normal blood-donors and juvenile diabetic patients inhibited Rb + accumulation and stimulated release of 51Cr and insulin in suspensions of dispersed pancreatic islet cells prepared from ob/ob mouse islets, which are rich in B-cells. The effects indicate the presence of a Bcytotoxic factor in human serum. Serum from mouse and fetal calf also inhibited the islet cell accumulation of Rb +. Toxicity was not suppressed by treating serum with protein A-Sepharose and did not correlate with islet cell binding of fluorescent antibodies to human immunoglobulin. Whereas all sera inhibited Rb + accumulation, 3 of 6 diabetic patient sera, but no blood-donor serum, made the cells fluoresce on exposure to the fluorescent antibodies. Supporting a dependence on complement, toxicity remained after dialysis, but was destroyed by treating serum with zymosan-A or heating at 56 ~ for 30 rain.
Five types of phenomena suggest that juvenile diabetes mellitus results from toxic influences on the pancreatic B-cells: 0 inflammation and lymphocyte infiltration of islets in recently diagnosed patients [1, 2] , ii) inhibited migration of patient's leucocytes on exposure to pancreas extracts [3, 4] , iii) correlation between the incidence of virus infections and the detection of new diabetic cases [5, 6] , iv) association of diabetes with histocompatibility antigens that may signify a disposition to increased virus susceptibility or adverse immunological responses [7, 8] , and v) binding of fluorescent antibodies against human immunoglobulin to islet sections treated with patient serum [9] [10] [11] .
Model experiments with alloxan showed Rb + accumulation in islet cells to be a sensitive parameter of at least one type of diabetogenic damage to B-cells [12, 13] . We therefore investigated the influence of diabetic patient serum on the B-cell accumulation of Rb +. These experiments led to the unexpected finding that serum in general is toxic to B-cells. Since this discovery may have important implications for the understanding of islet function and diabetes, a first characterization of the B-cytotoxic serum effect is reported.
Materials and Methods

86Rb Accumulation and Release of 51Cr and lnsulin
Suspensions of ob/ob mouse islet cells [14, 15] were incubated with or without serum in tissue culture medium 199 [16] supplemented with 5 mmol/1 Dglucose, 10 g/1 human serum albumin and 20 retool/1 N-hydroxyethylpiperazine-N'-2-ethanesulphonic acid and equilibrated with ambient air (TCM). Islet cell accumulation of 86Rb+ at 37 ~ was measured as previously [15] , except that sucrose [17] instead of inulin [15] was used as an extracellular water marker. In brief, cells were incubated with 28 ~tmol/1 86RbC1 (0.7 Ci/mmol) and 8 p~mol/1 (6,6'-3H2) sucrose (2 Ci/mmol) in 300 gl TCM for 2 h, centrifuged through oil, and analyzed by twochannel liquid-scintillation counting.
To study release of 51Cr [18] , cells were incubated for 60 rain at 37 ~ in 1 ml TCM supplemented with 0.4-0.9 gmol/1 Naz5aCrO4 (57 Ci/mmol). They were then washed with 10 ml TCM, centrifuged for 0012-186X/78/0014/0025/$1.40 5 min (50 g), and incubated for 2 h in 300 ~tl nonradioactive TCM containing 25 or 50% blood-donor serum, or blood-donor serum that had first been held at 56 ~ for 30 min; control cells were incubated in serum-free TCM. Incubation was ended by centrifuging through oil [15] , and 51Cr in medium and cell pellet measured.
To study release of insulin, cells were incubated at 37 ~ for 30, 60 or 120 min in 100 ~tl TCM (5 mmol/1 glucose) containing no serum, 75% blooddonor serum, or 75% blood-donor serum that had first been held at 56 ~ for 30 min. After incubation, 10 ml TCM was added, the cells were centrifuged for 5 min (50 g), and insulin in medium and cell pellet radioimmunologically assayed with crystalline mouse insulin as reference.
centrifugation to remove insoluble zymosan; analogous treatment of TCM with zymosan-A had no effect on the islet cell uptake of Rb +. In other experiments we attempted to remove IgG by shaking 2 ml of serum at 4 ~ for 2 h with 1 ml of protein Asepharose gel that had first been washed 4 times with several volumes of 0.1 mol/1 NaCI in 10 mmol/1 N-hydroxyethylpiperazine-N'-2-ethanesulphonic acid buffer (pH 7.4); according to the manufacturer, protein-A-sepharose binds 25 mg of IgG/ml gel. Before the treated serum was added to TCM and cells, protein A-sepharose was removed by centrifugation; analogous treatment of TCM with protein A-sepharose had only a marginal effect on Rb + accumulation (uptake was 88 _+ 5% of that in cells incubated in untreated TCM).
Immunofluorescent Staining
Cells incubated at 30 ~ for 30 min in 100 ~tl TCM with or without serum were diluted with 10 ml TCM, centrifuged (50 g, 5 rain), resuspended and then incubated for 1 h at 30 ~ with fluoresceinisothiocyanate-conjugated antibodies to human immunoglobulin (commercial antibodies diluted 1 : 10 with TCM in 100 gl final volume). After centrifugation as above and resuspension in TCM, cells were inspected in a fluorescence microscope equipped with a Zeiss epicondensor. Cells were also centrifuged in glass capillaries (10 ~tl disposable pipettes from Drummond Scientific Co., Broomall, Pa.); after mounting capillaries in immersion oil between object and cover glasses, the pellet fluorescence was measured under incident excitation [10] . TCM, antibodies and serum used in fluorescent staining experiments were Millipore-filtered (0.45 ~tm pore).
Collection and Treatment of Blood Serum
Normal serum was from 15 healthy blood-donors in Umefi and from mice and guinea-pigs of Ume5 colonies. Serum was also obtained from 5 male and 1 female juvenile diabetic patients at the Steno Memorial Hospital, Denmark. Three of these patients had sera with islet cell antibodies, as diagnosed by indirect fluorescent staining of islet sections of human blood-group 0 pancreatic glands [11] . Patients were 5-28 years of age and had not been treated with insulin. All sera were kept at -90 ~ until used within a year. Glucose was determined in pooled normal sera and adjusted to a final concentration of 5 mmol/1.
To inactivate the third complement factor in some experiments, 500 ~tl of serum was incubated with 10 mg of zymosan-A at 37 ~ for 2 h, followed by Chemicals 86RbC1 and (6,6'-3H2)sucrose were from the Radiochemical Centre, Amersham, England; Na251CrO4 from New England Nuclear, Boston, Mass.; Sepharose-linked protein A of Staphylococcus aureus (CI-4 B) from Pharmacia Fine Chemicals, Uppsala, Sweden; zymosan-A from Sigma Chemical Co., St. Louis, Mo.; fluoresceinisothiocyanate-conjugated rabbit antibodies to whole human immunoglobulin from Miles Laboratories Inc., Elkhart, Ind.; fetal calf serum and tissue culture medium 199 from the National Bacteriological Laboratories, Stockholm, Sweden, and human serum albumin from AB Kabi, Stockholm, Sweden.
Results
Effects of Serum on Rb + Accumulation by Islet Cells
Cells of intact [17] or broken [15] islets accumulate Rb + when incubated in the absence of serum. Figure 1 shows that 10% serum from normal blooddonors reduced the amount of Rb + appearing in the cell pellet by about one-half; 50% serum was completely inhibitory. Sera from mouse, guinea-pig, fetal calf, or newly diagnosed juvenile diabetic patients were also inhibitory, although species differences exist in the dose-response relationship ( Fig.   1 ).
The inhibitory effect of serum on Rb + accumulation was reproduced with plasma (Table 1) . It persisted after dialysis (Fig. 1) or treatment of serum with protein A-sepharose (Table 1 ). Heating at 56 ~ for 30 rain virtually abolished the effect of human serum or plasma and partially diminished that of mouse or fetal calf serum. Treatment of serum with zymosan-A also prevented the inhibition of Rb + accumulation (Table 1) . A mixture of 50% heat-inactivated serum and 5% non-inactivated serum did not inhibit Rb + accumulation much more than 5% non-inactivated serum alone ( Table 1 ). The effect of serum was not due to albumin, since the Rb + accumulation was 100%, 106%, or 108% when serum-free TCM contained crystalline human serum albumin at the concentration of 1, 10, or 20 g/l
(mean values of 2 experiments).
Effects of Serum on the Release of 51Cr and Insulin from Islet Cells
Human serum induced insulin release (Fig. 2) as well as release of SlCr from NazStCrO4-1abelled cells (Fig. 3) ; mild heating (56 ~ 30 rain) of serum inhibited these effects (Figs. 2 and 3 ). Incubation with serum had no demonstrable effect on the sedimentation of DNA during low-speed (50 g, 5 min) centrifugation of cells (not shown).
Staining of Serum-Treated Islet Cells for Antibody-Like Material
Incubating cells with blood-donor sera or sera from 3 of the diabetic patients did not result in a positive Parallel incubations were performed in TCM alone and in TCM supplemented as indicated. Serum was pooled from several healthy blood-donors; heparin plasma was from one donor. Results are given as mean values _+ SEM of the numbers of experiments stated in parentheses; each experiment was performed with a separate preparation of islet cells on a separate day and is not included in Figure 1 immunofluorescent staining of the cell surfaces for immunoglobulin. Sera from the remaining 3 patients made the surface of islet cells fluoresce on exposure to the fluoresceinisothiocyanate-conjugated immunoglobulin antibodies (Fig. 4a/b) . A ringshaped (Table 2) . Non-specific adsorption of antibodies occurred as shown by incubations in absence of serum. Cells incubated with 75% diabetic patient serum showed the highest mean value; the difference from 7.5% diabetic serum has a chance probability of less than 10% (two-tailed t test on paired data). Analysis of individual data revealed a correlation between values measured with or without exposure to serum, probably reflecting between-experiment variations in non-specific adsorption of fluorescent antibodies. The regression of fluorescence after treatment with serum on that after treatment with fluoresceinisothiocyanate-conjugated antibodies alone did not differ significantly in slope or height between blooddonor and diabetic patient serum. Regression analysis showed that the fluorescence induced by one patient's serum (186 arbitrary units) deviated significantly from the value predicted by regression in the combined blood-donor and diabetic group (P < 0.01 ; t test with correction of d.f. for non-random selection of deviating value). This diabetic patient's serum also gave the most prominent impression of ring-shaped staining on visual inspection of cells (Fig. 4a, b) . This serum did not have an extraordinarily great effect on Rb + accumulation and was negative when tested for islet cell antibodies with the aid of frozen sections of human pancreas [11] ; conversely, one of the 3 sera giving a negative reaction with human pancreas was positive when tested here for immunofluorescent staining of viable mouse B-cells. That the fluorescence seen and measured was due to fluoresceinisothiocyanate-conjugated antibodies is evident from the spectra observed in the microscope fluorimeter (Fig. 4c) .
Discussion
The results leave no doubt that mouse B-cells are adversely affected by serum. Drastic inhibition of Rb + accumulation has previously been observed only in response to chloromercuribenzene-p-sulphonic acid, which increases B-cell permeability to cations [17, 21] , or the established B-cytotoxic and diabetogenic compound, alloxan [12] . Enhancement of 5~Cr release in other cells parallels uptake of Trypan Blue and is recognized as diagnostic of decreased cell viability [18] . The serum-induced release of insulin may be leakage from damaged cells or an activation of the secretory apparatus due to altered transmembrane cationic conditions; an initial en- Effect of diluting diabetic patient serum -33_+15
After incubation under conditions indicated, cells were pelleted in glass capillaries and the pellet fluorescence emitted at 530 nm measured with 480 nm excitation wave-length. Mean values _+ SEM of experiments with individual sera from 6 different blood-donors and 6 diabetic patients are given. Two concentrations of diabetic patient serum (75% and 7.5%) were tested in each experiment. The mean _+ SEM of the differences in fluorescence obtained with these two concentrations are shown in the bottom row. The arbitrary unit of fluorescence is proportional to the microscope fluorimeter readings hancement of insulin release has been observed in response to both organic mercurials [22] and alloxan [23] , although both compounds are ultimately lethal to the B-cells. It is not known whether human B-cells are as sensitive as mouse B-cells to the toxic action of serum. An entirely different behaviour of human B-cells is not to be expected, however, since human and mouse B-cells are morphologically and physiologically very similar. The results with mouse serum show that serum and islets need not be from different species for the B-cytotoxic effect to occur.
It seems important to ask whether B-cells can be exposed to the toxic serum factor in vivo. The toxicity of serum was not lost during dialysis, so the responsible factor is not a small molecule. Since islet inflammation and interstitial pancreas fibrosis have been observed in recently diagnosed patients [1, 2, 4] , onset of juvenile diabetes may well be associated with extravasation of serum factors in the islets. Insulitis in children dying with Coxsackie B virus infection and in virus-infected mice [4, 24] indicates that viruses may induce islet inflammation. The islet morphology in mice immunized with homologous islet extracts suggests the possibility of autoimmune inflammatory reactions [25] ; it is not known, however, whether the islet cell antibodies described in diabetic patients [9] [10] [11] are secondary to islet damage or of other, say virus-mediated, cause [26] .
Whatever the primary cause of islet inflammation, the present results suggest that activation of a physiological, but potentially toxic, serum factor could perhaps be sufficient to cause the B-cell damage resulting in diabetes. Whether this proposal is of mere theoretical interest or covers the real situation in vivo cannot, of course, be decided on the basis of in vitro experiments alone.
Experiments were performed to test whether the toxic serum factor relates to the immunological system. Attempts to demonstrate an involvement of IgG immunoglobulins failed, since toxicity persisted after treating serum with protein A-Sepharose. Moreover, the toxic effect did not correlate with the islet cell binding of fluorescent antibodies to whole human immunoglobulin. Although 5% non-inactivated serum did not restore the toxicity of 50% heat-inactivated serum, the marked suppression of toxicity by zymosan-A or mild heating suggests a dependence on complement [27] .
The fluorescent staining results support previous reports of islet cell antibodies in diabetic patient serum [9] [10] [11] . In 3 of 6 cases surface staining of the dispersed mouse islet cells was observed; in one case staining was objectively proven by quantitative microscope fluorimetry. The ob/ob mouse islets have more than 90% B-cells which, on dispersion, retain viability as judged from their morphology, secretory response to glucose, accumulation of Rb +, and exclusion of Trypan Blue [13] [14] [15] 28] . The preparation could therefore be useful for extended studies of antibody binding to living B-cell surfaces. It is noteworthy, however, that the staining of mouse B-cells did not show a perfect correlation with the presence of islet cell antibodies diagnosed with frozen sections of human pancreas [1I] . Larger series of patients and other functional tests are required to decide the frequency, nature and possible toxic effects of the stained antibody-like material. However, it is already clear that any adverse effect of islet-cell antibodies should be distinguished from the definite and very marked B-cytotoxic action of serum from both normal and diabetic man.
Cultures of islet explants are increasingly used for long-term studies of islet cells, although several factors still make it difficult to maintain normal function of the cells. Some authors prefer culturing in serum-free medium [29, 30] , whereas others recommend the inclusion of serum [31] [32] [33] . Our results suggest that removal of complement by zymosan or mild heating may be worthwhile when culturing islets in serum-containing media. Fibroblasts are generally cultured with serum, but in contrast to islet cells they have been reported to exhibit enhanced Rb + uptake in response to serum [34] .
